North American venture capital entity iGan Partners has invested in DOCSI, a US-based surgeon-founded technology company that aims to enhance perioperative supply chain management with its mobile-first technology.

Through DOCSI, surgical centres and hospitals digitise surgical preference-card processes, engaging surgeons, and cutting down on supply expenses, all without necessitating intricate IT system integrations.

DOCSI CEO Andrew DeLeeuw said: "We're thrilled to welcome iGan Partners as a strategic investor.

"Their deep expertise in scaling healthcare technology companies will help us accelerate our mission to eliminate surgical waste, improve physician engagement, and simplify supply chain decisions for health systems."

DOCSI's platform, which has been adopted by health networks such as Allina Health, aims to minimise waste, standardise supplies, and drive cost savings.

iGan founder and managing partner Sam Ifergan said: "At iGan Partners, we invest in solutions that deliver practical, measurable impact.

"DOCSI's scalable platform aligns perfectly with our mission to modernise critical healthcare workflows—lowering costs, reducing variation, and empowering clinicians."

DOCSI was founded by a surgeon and focuses on enhancing supply chain efficiency. Its surgical preference dashboard is designed to be user-friendly and requires minimal IT support.

Earlier this year, iGan invested in Cyborg, a firm in building confidential AI infrastructure tailored to satisfy the rigorous privacy and compliance demands of regulated sectors, including healthcare.

In September 2023, the company partnered with St Andrews Medical Center and Previta, two healthcare entities based in Mexico, to improve access to quality healthcare and healthcare technologies across Mexico, Canada, and the US.